Your browser doesn't support javascript.
loading
DriverGenePathway: Identifying driver genes and driver pathways in cancer based on MutSigCV and statistical methods.
Xu, Xiaolu; Qi, Zitong; Zhang, Dawei; Zhang, Meiwei; Ren, Yonggong; Geng, Zhaohong.
Afiliação
  • Xu X; School of Computer and Information Technology, Liaoning Normal University, Dalian 116029, China.
  • Qi Z; Department of Statistics, University of Washington, Seattle, WA 98195, USA.
  • Zhang D; School of Computer and Information Technology, Liaoning Normal University, Dalian 116029, China.
  • Zhang M; Center for Reproductive and Genetic Medicine, Dalian Women and Children's Medical Group, Dalian 116037, China.
  • Ren Y; School of Computer and Information Technology, Liaoning Normal University, Dalian 116029, China.
  • Geng Z; Department of Cardiology, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Comput Struct Biotechnol J ; 21: 3124-3135, 2023.
Article em En | MEDLINE | ID: mdl-37293242
ABSTRACT
Although computational methods for driver gene identification have progressed rapidly, it is far from the goal of obtaining widely recognized driver genes for all cancer types. The driver gene lists predicted by these methods often lack consistency and stability across different studies or datasets. In addition to analytical performance, some tools may require further improvement regarding operability and system compatibility. Here, we developed a user-friendly R package (DriverGenePathway) integrating MutSigCV and statistical methods to identify cancer driver genes and pathways. The theoretical basis of the MutSigCV program is elaborated and integrated into DriverGenePathway, such as mutation categories discovery based on information entropy. Five methods of hypothesis testing, including the beta-binomial test, Fisher combined p-value test, likelihood ratio test, convolution test, and projection test, are used to identify the minimal core driver genes. Moreover, de novo methods, which can effectively overcome mutational heterogeneity, are introduced to identify driver pathways. Herein, we describe the computational structure and statistical fundamentals of the DriverGenePathway pipeline and demonstrate its performance using eight types of cancer from TCGA. DriverGenePathway correctly confirms many expected driver genes with high overlap with the Cancer Gene Census list and driver pathways associated with cancer development. The DriverGenePathway R package is freely available on GitHub https//github.com/bioinformatics-xu/DriverGenePathway.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article